Medicaid – ACHP

Providing Top-Notch Care to Our Most Vulnerable Neighbors

Temporary expansion of Medicaid benefits during the COVID-19 pandemic has been essential for some of our most vulnerable neighbors, filling a coverage and care gap that previously left health care inaccessible to millions. ACHP advocates for policies that advance capitated managed care and vital social services for working Americans.

Facts & Figures

On average, ACHP Medicaid plans earn

a full rating higher

from NCQA than other plans on key preventive measures

Recent

Bright Spot: Geisinger Health Plan Tackles Childhood Obesity Through Community Programs

Learn how Geisinger Health Plan improves children’s health through nutrition …

01/28/2026

ACHP Joins MMIA H.R. 1 Sign-on Letter

01/22/2026

Letter

ACHP Statement on Voluntary GLP-1 Model from CMS

ACHP released a statement in response to the voluntary BALANCE …

12/23/2025

Statement

ACHP Letter to CMS on Implementation of OBBBA Medicaid Provisions

11/05/2025

Letter

Regional, Nonprofit Health Plans Lead in 2025 NCQA Quality Ratings

11/04/2025

Press Release

Featured

ACHP Informs Coalition Medicaid Policy Paper

The Connecting to Coverage Coalition (CCC) represents a diverse collection …

06/21/2024

Issue Briefs

Medicaid Redeterminations: ACHP Members’ Efforts to Protect Access to Coverage

In this blog, ACHP's Nissa Shaffi discusses efforts by member …

10/26/2023

Blog

OP-ED: How to Fix American Health Care, According to 6 Experts

ACHP Chief Medical Officer Dr. Jennifer Lee and five other …

10/18/2022

Op-eds/Columns

Recommendations to CMS on Streamlining Medicaid and CHIP

The Alliance of Community Health Plans (ACHP) has provided recommendations …

11/08/2022

Letter

Health Care Policy Reform Discussion at thINc360

At thINc360, Ceci Connolly speaks with industry leaders about health …

08/15/2022

Events

Advancing Health Equity

ACHP's policy paper outlines how policy changes can address inequities …

04/19/2022

Issue Briefs

Contacts

Emma Liebman

Associate Director, Policy

Email Emma

Resource Library Search

Search by

ACHP Statement on CY2027 Medicare Advantage and Part D Rate Notice

04/06/2026

Statement

ma for tomororw / Medicare Advantage

ACHP Statement on CY2027 Medicare Advantage and Part D Final Rule

ACHP issued a statement in response to the CY2027 Medicare Advantage and Part D Final Rule.

04/02/2026

Statement

ma for tomorrow / Medicare Advantage / Part D / quality

ACHP Letter to FDA on Direct-to-Consumer Drug Advertising

03/30/2026

Letter

affordability / health costs / consumer experience / drug pricing / generic drugs /biosimilars / prescription drugs / drug prices

Bright Spot: OhioHealthy’s Comprehensive Health Condition Management Program

03/18/2026

Blog

chronic conditions / chronic disease pledge

ACHP Supports the Biosimilar Red Tape Elimination Act

ACHP letter backing H.R. 5526/S. 1954, which would eliminate the separate interchangeability designation for FDA-approved biosimilars, reducing costs and expanding patient access to lower-priced biologic therapies.

03/16/2026

Letter

affordability / health costs / drug pricing / generic drugs /biosimilars / prescription drugs / drug prices

ACHP Comment Letter on HHS Notice of Benefit and Payment Parameters for 2027

ACHP submitted a comment letter to CMS Administrator Oz on the HHS Notice of Benefit and Payment Parameters for 2027, outlining key priorities to strengthen the ACA Marketplace for regional …

03/10/2026

Letter

affordability / health costs / commercial market / consumer experience / individual market / ACA / Affordable Care Act / risk adjustment / Trump Admin

ACHP Statement on 2027 Medicare Advantage Advance Notice

ACHP responds to CMS's 2027 Medicare Advantage Advance Notice, urging accurate payments, rate sustainability and stronger protections for seniors and health plans.

02/26/2026

Statement

ma for tomorrow / Medicare Advantage

ACHP Comment Letter: CY 2027 Medicare Advantage Advance Notice

ACHP submitted comments to CMS on the CY 2027 Medicare Advantage Advance Notice, urging reforms to risk adjustment, the effective growth rate, USPCC calculations and Star Ratings to support regional …

02/25/2026

Letter

affordability / health costs / drug pricing / GLP-1s / ma for tomorrow / Medicare / Medicare Advantage / Part D / prescription drugs / drug prices / quality ratings / risk adjustment / Telehealth / telemedicine / Trump Admin / Value-based care

ACHP Comments on HHS AI in Clinical Care RFI

ACHP urges HHS to accelerate responsible AI adoption in health care through coordinated federal policy, modernized reimbursement and stronger patient protections.

02/23/2026

Letter

AI / data sharing / interoperability / health IT

ACHP Statement on Passage of Critical Health Care Legislation

ACHP applauds Congress for working in a bipartisan manner to advance meaningful reforms for patients, demonstrating that a thoughtful, collaborative process can deliver strong results.

02/03/2026

Statement

affordability / health costs / PBMs / pharmacy benefit managers / price transparency / Telehealth / telemedicine / Trump Admin

1 2 3 4 … 54